SCHEMBL4456694

SCHEMBL4456694

[CH2]c1cccc(-c2ccc(Cl)cc2)c1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 1/20 0.42
SLC6A3 Q01959 1/20 0.42
PTGS2 P35354 2/20 0.42
SUCNR1 Q9BXA5 1/20 0.38
CYP1A2 P05177 2/20 0.38
PTGS1 P23219 1/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TGFBR1 P36897 1/20 0.36
PDCD1 Q15116 2/20 0.36
CD274 Q9NZQ7 2/20 0.36
MEN1 O00255 1/20 0.36
CYP2C19 P33261 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HTR1A P08908 2/20 0.36
HTR7 P34969 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL192333 0.81 PDCD1 (0.53) PTGS2HPGDHSD17B10PDCD1CD274
SCHEMBL13176495 0.79 NPC1 (0.47) SLC6A4SLC6A3PTGS2SUCNR1CYP1A2
SCHEMBL2688189 0.79 CYP1A2 (0.50) SLC6A4SLC6A3PTGS2CYP1A2PTGS1
SCHEMBL28664909 0.73 CD274 (0.50) SLC6A4SLC6A3PTGS2SUCNR1CYP1A2
SCHEMBL12295922 0.71 CYP1A2 (0.50) SLC6A4SLC6A3PTGS2CYP1A2PTGS1
SCHEMBL9862848 0.70 CYP1A2 (0.63) SLC6A4SLC6A3PTGS2CYP1A2PTGS1
SCHEMBL172733 0.70 NPC1 (0.59) SLC6A4SLC6A3PTGS2CYP1A2PTGS1
SCHEMBL30493964 0.70 NPC1 (0.59) SLC6A4SLC6A3PTGS2CYP1A2PTGS1
SCHEMBL2815641 0.69
SCHEMBL4328698 0.69 NPC1 (0.46) SLC6A4SLC6A3PTGS2CYP1A2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2052251-A1 COMBINATION 5-HT7 RECEPTOR ANTAGONIST AND SEROTONIN REUPTAKE INHIBITOR THERAPY JANSSEN PHARMACEUTICA N.V. (BE) 2009-04-29 EP disclosed
WO-2008013556-A1 COMBINATION 5-HT7 RECEPTOR ANTAGONIST AND SEROTONIN REUPTAKE INHIBITOR THERAPY JANSSEN PHARMACEUTICAL N.V. (BE) 2008-01-31 WO disclosed